1. Pyun, Jung-Min, Park, Young Ho, Hodges, Angela, Saykin, Andrew J, Nho, Kwangsik. 2022. Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology. In Alzheimer's & dementia (Amsterdam, Netherlands), 14, e12317. doi:10.1002/dad2.12317. https://pubmed.ncbi.nlm.nih.gov/35769874/
2. Hur, Ji-Yeun, Frost, Georgia R, Wu, Xianzhong, Goate, Alison, Li, Yue-Ming. 2020. The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease. In Nature, 586, 735-740. doi:10.1038/s41586-020-2681-2. https://pubmed.ncbi.nlm.nih.gov/32879487/
3. Sahranavard-Pirbazari, Parisa, Khoshghiafeh, Azin, Kamali, Mohammad Javad, Bakhtiari, Marzieh, Ahmadifard, Mohamadreza. 2023. A comprehensive review of ACE2, ACE1, TMPRSS2 and IFITM3 gene polymorphisms and their effect on the severity of COVID-19. In Advances in medical sciences, 68, 450-463. doi:10.1016/j.advms.2023.10.010. https://pubmed.ncbi.nlm.nih.gov/37926001/
4. Liu, Xinnan, Zhang, Weiqi, Han, Yichao, Li, Hecheng, Li, Bin. 2024. FOXP3+ regulatory T cell perturbation mediated by the IFNγ-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity. In Nature communications, 15, 122. doi:10.1038/s41467-023-44391-9. https://pubmed.ncbi.nlm.nih.gov/38167862/
5. Yánez, Diana C, Ross, Susan, Crompton, Tessa. 2019. The IFITM protein family in adaptive immunity. In Immunology, 159, 365-372. doi:10.1111/imm.13163. https://pubmed.ncbi.nlm.nih.gov/31792954/